<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Interpretation of lung biopsy results in interstitial lung disease</title><link href="/z/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/z/d/css/icofont.min.css" rel="stylesheet"/><link href="/z/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/z/d/css/animate.css" rel="stylesheet"/><link href="/z/d/css/owl.carousel.css" rel="stylesheet"/><link href="/z/d/css/magnific-popup.css" rel="stylesheet"/><link href="/z/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/z/d/css/style.css" rel="stylesheet"/><link href="/z/d/css/rtl_edited.css" rel="stylesheet"/><link href="/z/d/css/responsive.css" rel="stylesheet"/><link href="https:///uptodate_assets/main.css" rel="stylesheet"/>
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>
<meta content="" name="description"/>
<link href="/z/d/img/favicon.png" rel="icon" type="image/png">
</link></head>
<body>
<!-- Start Main Menu Area -->
<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>
<section class="teacher-area ptb-10">
<div class="container">
</div>
<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Interpretation of lung biopsy results in interstitial lung disease</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Interpretation of lung biopsy results in interstitial lung disease</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Talmadge E King, Jr, MD</a></dd><dt><span> </span>Section Editors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Kevin R Flaherty, MD, MS</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Andrew Nicholson, MD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Henri G Colt, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Paul Dieffenbach, MD</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Aug 01, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H5485849"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>The diffuse parenchymal lung diseases, often collectively referred to as the interstitial lung diseases (ILDs), are a heterogeneous group of disorders that are classified together because of similar clinical, radiographic, physiologic, or pathologic manifestations  (<a class="graphic graphic_algorithm graphicRef77345" href="/z/d/graphic/77345.html" rel="external">algorithm 1</a>). When the results of clinical evaluation, laboratory testing, imaging studies including high-resolution computed tomography (HRCT), and pulmonary function testing do not allow the clinician to make a confident diagnosis of a given type or stage of ILD, lung biopsy with careful examination of lung tissue is often necessary  (<a class="graphic graphic_algorithm graphicRef69044" href="/z/d/graphic/69044.html" rel="external">algorithm 2</a>).</p><p>The clinicopathologic interpretation of lung biopsy results in adults with ILD will be reviewed here. The clinical evaluation, diagnostic testing, radiographic patterns, role of bronchoalveolar lavage, and role of lung biopsy in ILD are discussed separately. (See  <a class="medical medical_review" href="/z/d/html/4310.html" rel="external">"Approach to the adult with interstitial lung disease: Clinical evaluation"</a> and  <a class="medical medical_review" href="/z/d/html/4358.html" rel="external">"Approach to the adult with interstitial lung disease: Diagnostic testing"</a> and  <a class="medical medical_review" href="/z/d/html/6988.html" rel="external">"High resolution computed tomography of the lungs"</a> and  <a class="medical medical_review" href="/z/d/html/4303.html" rel="external">"Basic principles and technique of bronchoalveolar lavage"</a> and  <a class="medical medical_review" href="/z/d/html/4308.html" rel="external">"Role of bronchoalveolar lavage in diagnosis of interstitial lung disease"</a> and  <a class="medical medical_review" href="/z/d/html/4379.html" rel="external">"Role of lung biopsy in the diagnosis of interstitial lung disease"</a>.)</p><p class="headingAnchor" id="H11388807"><span class="h1">MULTIDISCIPLINARY DISCUSSION</span><span class="headingEndMark"> — </span>Most cases of ILD require careful clinical, radiologic, and pathological correlation, preferably in the setting of a multidisciplinary discussion, to arrive at the most accurate final diagnosis [<a href="#rid1">1-6</a>]. Histologic abnormalities alone are rarely specific in ILD. More often, the findings are "characteristic" or "consistent with" a specific diagnosis. "Nonspecific" reaction patterns are common to several diseases that cause inflammation and/or fibrosis in the lungs [<a href="#rid7">7</a>]. Small tissue samples and substantial inter-observer variability among pathologists further complicate interpretation [<a href="#rid8">8-10</a>].</p><p>With a multidisciplinary approach, surgical lung biopsy produces a definitive diagnosis in more than 90 percent of cases of ILD occurring in immunocompetent hosts [<a href="#rid1">1,11,12</a>]. The role for sequential transbronchial lung cryobiopsy remains ill-defined [<a href="#rid13">13-16</a>].</p><p>Data provided to the pathologist by the clinician at the time of biopsy should include:</p><p class="bulletIndent1"><span class="glyph">●</span>The age and sex of the patient</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Duration of respiratory illness</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Immunocompetence of the patient</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Smoking history</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>History of exposures to occupational or environmental agents (eg, asbestos, beryllium, silica, birds, diisocyanates, humidifier)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Evidence for or against underlying connective tissue disease</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Radiographic findings including character, distribution, and time course of abnormalities</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Suspected clinical diagnosis, which will often lead to a more targeted search by the pathologist</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Detailed history of drug use (prescribed or illicit)</p><p></p><p>Virtually all histopathologic patterns of lung injury have been described in association with one or more drugs, including usual interstitial pneumonia, nonspecific interstitial pneumonia, desquamative interstitial pneumonia, eosinophilic pneumonia, hypersensitivity pneumonia, organizing pneumonia, diffuse alveolar damage, alveolar hemorrhage, and rarely, non-necrotizing granulomatosis, pulmonary veno-occlusive disease, and alveolar proteinosis. Thus, drug-induced lung toxicity is in the differential diagnosis of all of the following histopathologic patterns.</p><p class="headingAnchor" id="H11388814"><span class="h1">INTERPRETATION OF HISTOPATHOLOGIC PATTERNS</span><span class="headingEndMark"> — </span>Histopathologic patterns of diffuse parenchymal lung disease can be broadly divided into interstitial pneumonias, granulomatous lung diseases, and other disorders  (<a class="graphic graphic_algorithm graphicRef77345" href="/z/d/graphic/77345.html" rel="external">algorithm 1</a>). Histopathologic patterns may be seen in combination and the pathologist should ascertain the predominant pattern, but also describe all that are present [<a href="#rid17">17</a>].</p><p class="headingAnchor" id="H11388821"><span class="h2">Interstitial pneumonias</span><span class="headingEndMark"> — </span>The interstitial pneumonias, a distinct subentity of interstitial lung disease (ILD), are classified according to seven histologic patterns: usual interstitial pneumonia (UIP), nonspecific interstitial pneumonia (NSIP), desquamative interstitial pneumonia (DIP), respiratory bronchiolitis (RB), organizing pneumonia (OP), lymphoid interstitial pneumonia (LIP), and diffuse alveolar damage (DAD)  (<a class="graphic graphic_algorithm graphicRef77345" href="/z/d/graphic/77345.html" rel="external">algorithm 1</a>) [<a href="#rid18">18</a>]. The histologic patterns that characterize the idiopathic interstitial pneumonias are also associated with other disease processes that need to be considered in the differential diagnosis. (See  <a class="medical medical_review" href="/z/d/html/4302.html" rel="external">"Idiopathic interstitial pneumonias: Classification and pathology"</a>.)</p><p class="headingAnchor" id="H5486863"><span class="h3">Usual interstitial pneumonia</span><span class="headingEndMark"> — </span>The histopathologic pattern of UIP is characterized by established fibrosis (collagen deposition) and loss of alveolar architecture with a patchy subpleural and paraseptal distribution; honeycombing may or may not be present. Fibroblastic foci (also known as fibrotic foci) are localized clusters of fibroblasts and myofibroblasts that lie in continuity with the established fibrosis and are a characteristic histologic feature of UIP  (<a class="graphic graphic_picture graphicRef58242" href="/z/d/graphic/58242.html" rel="external">picture 1</a>). These abnormalities are typically associated with a mild chronic inflammatory cell infiltrate. In addition to the presence of fibroblastic foci, a chief diagnostic criterion is temporal heterogeneity, such that areas of normal lung, interstitial inflammation, fibrosis, and honeycomb change are interspersed. (See  <a class="medical medical_review" href="/z/d/html/4302.html" rel="external">"Idiopathic interstitial pneumonias: Classification and pathology"</a> and  <a class="medical medical_review" href="/z/d/html/4302.html" rel="external">"Idiopathic interstitial pneumonias: Classification and pathology", section on 'Usual interstitial pneumonia'</a>.)</p><p>The histologic pattern of UIP is most commonly associated with the type of idiopathic interstitial pneumonia called idiopathic pulmonary fibrosis (IPF, previously described as cryptogenic fibrosing alveolitis) [<a href="#rid19">19</a>]. However, UIP is also seen in diseases other than IPF, such as hypersensitivity pneumonitis, rheumatoid arthritis, scleroderma, and asbestosis. In these instances, there are often features that make a definite diagnosis of the UIP pattern less likely, such as the absence of fibroblastic foci or the presence of isolated giant cells, ill-formed granuloma, lymphoid follicles, or asbestos bodies. The histopathology should always be correlated with clinical (eg, asbestos or organic dust exposure, Raynaud’s phenomenon, dry eyes/mouth, joint pain/stiffness, skin changes) and radiographic (eg, calcified pleural plaques) findings to ensure that the rare situation in which UIP is associated with a disease other than IPF is not missed [<a href="#rid20">20</a>]. Potential causes (or associations) of UIP are shown in the table  (<a class="graphic graphic_table graphicRef61334" href="/z/d/graphic/61334.html" rel="external">table 1</a>).</p><p class="headingAnchor" id="H5486856"><span class="h3">Nonspecific interstitial pneumonia</span><span class="headingEndMark"> — </span>The main histologic feature of NSIP is diffuse and homogeneous interstitial and chronic inflammation, characterized by varying degrees of mononuclear cell inflammation with or without fibrosis. Some cases have a primarily chronic inflammatory/cellular pattern ("cellular NSIP")  (<a class="graphic graphic_picture graphicRef72988" href="/z/d/graphic/72988.html" rel="external">picture 2</a>), but most cases have a fibrotic pattern ("fibrotic NSIP")  (<a class="graphic graphic_picture graphicRef58583" href="/z/d/graphic/58583.html" rel="external">picture 3</a>) [<a href="#rid21">21</a>]. (See  <a class="medical medical_review" href="/z/d/html/4306.html" rel="external">"Treatment and prognosis of nonspecific interstitial pneumonia"</a> and  <a class="medical medical_review" href="/z/d/html/4302.html" rel="external">"Idiopathic interstitial pneumonias: Classification and pathology", section on 'Nonspecific interstitial pneumonia'</a>.)</p><p>While NSIP may have significant fibrosis, the overall histopathologic pattern is usually diffuse and has a pathologically uniform age. Fibroblastic foci and honeycombing, if present, are rare. These features are essential in distinguishing NSIP from UIP. Nonetheless, fibrotic NSIP can be difficult to reliably distinguish from UIP and there is significant inter-observer variability even among expert histopathologists [<a href="#rid8">8,10</a>].</p><p>NSIP can be idiopathic or associated with a number of medical conditions, such as healing viral pneumonias, connective tissue disease, HIV infection, hypersensitivity pneumonitis, and drug-induced toxicity  (<a class="graphic graphic_table graphicRef60068" href="/z/d/graphic/60068.html" rel="external">table 2</a>). A large number of drugs have been associated with the NSIP pattern (eg, <a class="drug drug_general" data-topicid="9704" href="/z/d/drug information/9704.html" rel="external">nitrofurantoin</a>, <a class="drug drug_general" data-topicid="9630" href="/z/d/drug information/9630.html" rel="external">methotrexate</a>, <a class="drug drug_general" data-topicid="8595" href="/z/d/drug information/8595.html" rel="external">amiodarone</a>, <a class="drug drug_general" data-topicid="9240" href="/z/d/drug information/9240.html" rel="external">chlorambucil</a>, <a class="drug drug_general" data-topicid="9206" href="/z/d/drug information/9206.html" rel="external">carmustine</a>), so a careful review of drug use is essential. (See  <a class="medical medical_review" href="/z/d/html/112195.html" rel="external">"Causes, clinical manifestations, evaluation, and diagnosis of nonspecific interstitial pneumonia", section on 'Definition'</a>.)</p><p class="headingAnchor" id="H5486870"><span class="h3">Desquamative interstitial pneumonia</span><span class="headingEndMark"> — </span>DIP is characterized by diffuse filling of alveoli with macrophages that have glassy eosinophilic cytoplasm and fine granular brown pigmentation (smoker’s macrophages). Other features that may be seen are mild interstitial chronic inflammation, type 2 cell hyperplasia, lymphoid follicles, and mild eosinophilic infiltration. Fibrosis may be present, but is generally mild [<a href="#rid22">22</a>].</p><p>DIP was originally thought to be a precursor of UIP. However, it now seems more likely that these are separate disease entities. The major cause of DIP is exposure to cigarette smoke. Other potential causes (or associations) of DIP are listed in the table  (<a class="graphic graphic_table graphicRef58956" href="/z/d/graphic/58956.html" rel="external">table 3</a>). (See  <a class="medical medical_review" href="/z/d/html/4302.html" rel="external">"Idiopathic interstitial pneumonias: Classification and pathology", section on 'Desquamative interstitial pneumonia'</a>.)</p><p class="headingAnchor" id="H5486877"><span class="h3">Respiratory bronchiolitis</span><span class="headingEndMark"> — </span>Respiratory bronchiolitis (RB) is characterized by a mononuclear inflammatory process involving the submucosa of the membranous and respiratory bronchioles; these changes may be associated with mild fibrosis that extends into the surrounding alveolar walls [<a href="#rid23">23</a>]. An accumulation of alveolar macrophages with fine, granular, tan or golden pigmentation (smoker’s macrophages) in the alveoli and small airways is typical [<a href="#rid23">23-25</a>]. The airway epithelium is abnormal, with goblet cell hyperplasia and metaplastic cuboidal epithelium, which often extends into the nearby alveolar septa and ducts [<a href="#rid23">23</a>]. (See  <a class="medical medical_review" href="/z/d/html/4319.html" rel="external">"Respiratory bronchiolitis-associated interstitial lung disease"</a> and  <a class="medical medical_review" href="/z/d/html/4302.html" rel="external">"Idiopathic interstitial pneumonias: Classification and pathology", section on 'Respiratory bronchiolitis-associated ILD'</a>.)</p><p>In the appropriate clinical setting (ie, clinical evidence of interstitial lung disease), the histologic pattern of RB indicates respiratory bronchiolitis-associated interstitial lung disease (RB-ILD). Other conditions that are associated with inflammation in the respiratory bronchioles are listed in the table  (<a class="graphic graphic_table graphicRef60250" href="/z/d/graphic/60250.html" rel="external">table 4</a>). Like DIP, exposure to cigarette smoke is the most common association.</p><p class="headingAnchor" id="H5486892"><span class="h3">Organizing pneumonia</span><span class="headingEndMark"> — </span>OP is the histologic pattern associated with cryptogenic organizing pneumonia (COP, previously called bronchiolitis obliterans organizing pneumonia or BOOP). (See  <a class="medical medical_review" href="/z/d/html/4332.html" rel="external">"Cryptogenic organizing pneumonia"</a>.)</p><p>The distribution of OP is often patchy and peribronchiolar, reflecting the patchy pattern seen on high-resolution computed tomography (HRCT). However, the histopathologic appearance is relatively uniform within involved areas  (<a class="graphic graphic_picture graphicRef72270" href="/z/d/graphic/72270.html" rel="external">picture 4</a>). Numerous buds of granulation tissue (loose accumulations of collagen-embedding fibroblasts and myofibroblasts) are present within alveoli, often involving alveolar ducts and small airways. When the granulation tissue is primarily within the airways, this type of inflammation is sometimes called proliferative bronchiolitis. Foamy macrophages are commonly seen in the alveoli, presumably secondary to bronchiolar occlusion. Mild chronic inflammation (lymphocytes and plasma cells) may be present; eosinophils and neutrophils are usually few in number, and severe fibrotic changes are unusual. (See  <a class="medical medical_review" href="/z/d/html/4323.html" rel="external">"Overview of bronchiolar disorders in adults", section on 'Proliferative bronchiolitis'</a>.)</p><p>OP occurs more often as a nonspecific reaction to lung injury or to another disease process than as the idiopathic process, COP. Common associations with OP are listed in the table  (<a class="graphic graphic_table graphicRef87710" href="/z/d/graphic/87710.html" rel="external">table 5</a>). In addition, OP can be seen in combination with the cellular interstitial changes of NSIP in cases of drug-toxicity (eg, <a class="drug drug_general" data-topicid="9630" href="/z/d/drug information/9630.html" rel="external">methotrexate</a>) and connective tissue disease (eg, rheumatoid arthritis) and as a minor feature in UIP. (See <a class="local">'Nonspecific interstitial pneumonia'</a> above and <a class="local">'Usual interstitial pneumonia'</a> above.)</p><p class="headingAnchor" id="H5486899"><span class="h3">Lymphoid interstitial pneumonia</span><span class="headingEndMark"> — </span>In LIP, there is a dense diffuse interstitial infiltrate of lymphocytes, plasma cells, and histiocytes; germinal centers and multinucleated giant cells may be present  (<a class="graphic graphic_table graphicRef69805" href="/z/d/graphic/69805.html" rel="external">table 6</a>). The lymphocytes are a polyclonal mixture of T and B cells. (See  <a class="medical medical_review" href="/z/d/html/4361.html" rel="external">"Lymphoid interstitial pneumonia", section on 'Pathologic findings'</a>.)</p><p>LIP was previously considered to be pre-neoplastic; however, it is now believed to be a reactive pulmonary lymphoid hyperplasia, similar to that seen in collagen vascular diseases or immunosuppression [<a href="#rid26">26,27</a>]. Potential causes (or associations) of LIP are listed in the table  (<a class="graphic graphic_table graphicRef70714" href="/z/d/graphic/70714.html" rel="external">table 7</a>). The appearance of hypersensitivity pneumonitis is similar, but hypersensitivity pneumonitis (HP) is more patchy and is associated with exposure to characteristic agents. (See  <a class="medical medical_review" href="/z/d/html/4361.html" rel="external">"Lymphoid interstitial pneumonia"</a> and <a class="local">'Granulomatous lung diseases'</a> below.)</p><p class="headingAnchor" id="H5486906"><span class="h3">Diffuse alveolar damage</span><span class="headingEndMark"> — </span>DAD is a nonspecific reaction to lung injury. The characteristic histopathologic features of DAD depend on when in the course of lung injury the biopsy is taken. During the exudative (acute) phase, there is interstitial edema, acute and chronic inflammation, type II cell hyperplasia, and hyaline membrane formation. Thrombi within small arteries are also common. During the organizing (healing) phase, the features are more similar to those of OP  (<a class="graphic graphic_picture graphicRef57964" href="/z/d/graphic/57964.html" rel="external">picture 5</a> and <a class="graphic graphic_picture graphicRef65804" href="/z/d/graphic/65804.html" rel="external">picture 6</a> and <a class="graphic graphic_picture graphicRef63702" href="/z/d/graphic/63702.html" rel="external">picture 7</a> and <a class="graphic graphic_picture graphicRef53033" href="/z/d/graphic/53033.html" rel="external">picture 8</a>) [<a href="#rid28">28-30</a>]. (See <a class="local">'Organizing pneumonia'</a> above.)</p><p>The histopathologic pattern of DAD is most common in patients with acute respiratory distress syndrome (ARDS), but is also seen in the other types of lung injury listed in the table  (<a class="graphic graphic_table graphicRef54819" href="/z/d/graphic/54819.html" rel="external">table 8</a>). When DAD is idiopathic, it is called acute interstitial pneumonia (AIP), which can occur on its own or in combination with other forms of interstitial pneumonia, such as idiopathic pulmonary fibrosis. (See  <a class="medical medical_review" href="/z/d/html/4302.html" rel="external">"Idiopathic interstitial pneumonias: Classification and pathology", section on 'Acute interstitial pneumonia'</a> and  <a class="medical medical_review" href="/z/d/html/4369.html" rel="external">"Acute interstitial pneumonia (Hamman-Rich syndrome)"</a> and  <a class="medical medical_review" href="/z/d/html/1637.html" rel="external">"Acute respiratory distress syndrome: Clinical features, diagnosis, and complications in adults"</a> and  <a class="medical medical_review" href="/z/d/html/14870.html" rel="external">"Clinical manifestations and diagnosis of idiopathic pulmonary fibrosis", section on 'Histopathology'</a>.)</p><p class="headingAnchor" id="H11388828"><span class="h2">Granulomatous lung diseases</span><span class="headingEndMark"> — </span>Granulomas are discrete aggregates of epithelioid histiocytes and T lymphocytes, with varying numbers of multinucleated Langhans-type giant cells (contain multiple nuclei arranged peripherally in a horseshoe pattern)  (<a class="graphic graphic_picture graphicRef64219" href="/z/d/graphic/64219.html" rel="external">picture 9</a>).</p><p>The noninfectious interstitial lung diseases associated with granuloma formation typically cause nonnecrotizing granulomas, rather than the necrotizing granulomas seen with infections. Regardless of whether necrosis is present, the first step in the evaluation is to exclude infection (eg, fungal, mycobacterial). Then, attention is turned to the noninfectious causes of granulomatous lung disease, which are listed in the table  (<a class="graphic graphic_table graphicRef56028" href="/z/d/graphic/56028.html" rel="external">table 9</a>).</p><p>Features of the more common granulomatous lung diseases are described in the following sections.</p><p class="headingAnchor" id="H5487037"><span class="h3">Sarcoidosis</span><span class="headingEndMark"> — </span>Sarcoidosis usually has a lymphangitic distribution with granulomas and comparatively little lymphocytic inflammation most commonly found in the alveolar septa and bronchial and pulmonary arterial walls. The granulomas are generally non-necrotizing, but focal central necrosis is occasionally present. Additional features that are sometimes seen include asteroid bodies, Schaumann bodies, and birefringent crystalline particles (calcium oxalate and other calcium salts)  (<a class="graphic graphic_picture graphicRef83308" href="/z/d/graphic/83308.html" rel="external">picture 10</a> and <a class="graphic graphic_picture graphicRef83306" href="/z/d/graphic/83306.html" rel="external">picture 11</a> and <a class="graphic graphic_picture graphicRef83307" href="/z/d/graphic/83307.html" rel="external">picture 12</a>). Bronchoalveolar lavage (BAL) shows an increase in the proportion of lymphocytes and elevation in the CD4/CD8 ratio &gt;1. (See  <a class="medical medical_review" href="/z/d/html/4353.html" rel="external">"Clinical manifestations and diagnosis of sarcoidosis"</a> and  <a class="medical medical_review" href="/z/d/html/4308.html" rel="external">"Role of bronchoalveolar lavage in diagnosis of interstitial lung disease", section on 'Lymphocytic BAL'</a>.)</p><p>A sarcoid-like disorder with granulomatous infiltration of the lungs and other organs may occur in patients with common variable immunodeficiency [<a href="#rid31">31,32</a>]. (See  <a class="medical medical_review" href="/z/d/html/3928.html" rel="external">"Clinical manifestations, epidemiology, and diagnosis of common variable immunodeficiency in adults"</a>.)</p><p class="headingAnchor" id="H5487030"><span class="h3">Chronic beryllium disease</span><span class="headingEndMark"> — </span>The histopathology of chronic beryllium disease looks virtually identical to sarcoidosis with nonnecrotizing granulomas and/or mononuclear cell infiltrates in the bronchial walls or lung interstitium. Chronic beryllium disease is characterized by a history of beryllium exposure, a positive blood or BAL beryllium lymphocyte proliferation test, and noncaseating granulomas on lung or bronchial biopsy. (See  <a class="medical medical_review" href="/z/d/html/4367.html" rel="external">"Chronic beryllium disease (berylliosis)", section on 'Diagnosis'</a>.)</p><p class="headingAnchor" id="H5487119"><span class="h3">Hypersensitivity pneumonitis</span><span class="headingEndMark"> — </span>In HP (also called extrinsic allergic alveolitis), the granulomas are generally bronchocentric [<a href="#rid33">33</a>]. Compared with sarcoid granulomas, HP granulomas are smaller, less discrete, and associated with greater interstitial chronic inflammation  (<a class="graphic graphic_picture graphicRef73426" href="/z/d/graphic/73426.html" rel="external">picture 13</a> and <a class="graphic graphic_picture graphicRef83309" href="/z/d/graphic/83309.html" rel="external">picture 14</a>). Other key features in differentiating HP and sarcoidosis are the history of exposure to an agent known to cause HP, serologic evidence of exposure, and a CD4/CD8 ratio in the BAL &lt;1. Fibrotic HP can be difficult to distinguish from other fibrosing interstitial pneumonias in biopsy specimens [<a href="#rid34">34,35</a>]. (See  <a class="medical medical_review" href="/z/d/html/4313.html" rel="external">"Hypersensitivity pneumonitis (extrinsic allergic alveolitis): Clinical manifestations and diagnosis", section on 'Surgical lung biopsy'</a> and  <a class="medical medical_review" href="/z/d/html/4308.html" rel="external">"Role of bronchoalveolar lavage in diagnosis of interstitial lung disease", section on 'Lymphocytic BAL'</a>.)</p><p class="headingAnchor" id="H5487023"><span class="h3">Langerhans cell granulomatosis</span><span class="headingEndMark"> — </span>The histopathology of pulmonary Langerhans cell histiocytosis (Histiocytosis X, eosinophilic granuloma) is characterized by cysts and variably dense aggregates of Langerhans cells (mononuclear dendritic cells, S-100 and CD1a positive), lymphocytes, plasma cells, and a few eosinophils. On electron microscopy, Langerhans cells have classic pentalaminar cytoplasmic inclusions or Birbeck granules. The disease is dynamic; thus, sometimes only stellate fibrous scars remain as the disease progresses. (See  <a class="medical medical_review" href="/z/d/html/4334.html" rel="external">"Pulmonary Langerhans cell histiocytosis", section on 'Lung biopsy'</a> and  <a class="medical medical_review" href="/z/d/html/4334.html" rel="external">"Pulmonary Langerhans cell histiocytosis", section on 'Background'</a>.)</p><p>Most cases of pulmonary Langerhans cell histiocytosis are diagnosed by HRCT showing mid to upper lung zone cysts and nodules in combination with the clinical history (eg, age 20 to 40 years, cigarette smoking). (See  <a class="medical medical_review" href="/z/d/html/4334.html" rel="external">"Pulmonary Langerhans cell histiocytosis", section on 'Evaluation'</a> and  <a class="medical medical_review" href="/z/d/html/8385.html" rel="external">"Clinical manifestations, pathologic features, and diagnosis of Langerhans cell histiocytosis", section on 'Pathologic features'</a>.)</p><p class="headingAnchor" id="H26634096"><span class="h3">Erdheim-Chester disease</span><span class="headingEndMark"> — </span>Another histiocytic proliferation that rarely affects the lungs is Erdheim-Chester disease (ECD). It has a more lymphangitic distribution, often with marked visceral pleural thickening. The hallmark of ECD is a dense infiltration of tissues by foamy or lipid-laden histiocytes, due to the accumulation of lipids within their cytoplasm. (See  <a class="medical medical_review" href="/z/d/html/13942.html" rel="external">"Erdheim-Chester disease", section on 'Other organs'</a> and  <a class="medical medical_review" href="/z/d/html/13942.html" rel="external">"Erdheim-Chester disease", section on 'Pathology'</a>.)</p><p class="headingAnchor" id="H8280996"><span class="h3">Foreign body granulomatosis</span><span class="headingEndMark"> — </span>The histopathology of foreign body granulomatosis (FBG) typically consists of perivascular fibrosis and aggregates of multinucleated giant cells and granulomas. Polarizable material may be seen within the granulomas and giant cells, or extracellularly in the vessel wall. FBG is caused by intravenous injection, or less commonly inhalation, of pulverized tablets. The talc or other foreign material from the tablets migrates through the pulmonary arterial wall to the surrounding perivascular and pulmonary interstitial tissue where it incites the granulomatous response.</p><p>The radiographic and pathologic changes of FBG occur predominately in a perihilar and upper lobe distribution. The clinical presentation, evaluation and management of foreign body granulomatosis is discussed separately. (See  <a class="medical medical_review" href="/z/d/html/4370.html" rel="external">"Foreign body granulomatosis"</a>.)</p><p class="headingAnchor" id="H5487044"><span class="h3">Diseases with associated vascular inflammation</span><span class="headingEndMark"> — </span>Granulomatosis with polyangiitis, eosinophilic granulomatosis with polyangiitis (EGPA, Churg-Strauss), necrotizing sarcoid granulomatosis, and pulmonary lymphomatoid granulomatosis are differentiated from sarcoidosis by their angiocentric pattern of inflammation and associated evidence of vasculitis. Well-formed granulomas without necrosis are uncommon [<a href="#rid3">3</a>]. (See  <a class="medical medical_review" href="/z/d/html/4330.html" rel="external">"Granulomatosis with polyangiitis and microscopic polyangiitis: Respiratory tract involvement"</a> and  <a class="medical medical_review" href="/z/d/html/4363.html" rel="external">"Epidemiology, pathogenesis, and pathology of eosinophilic granulomatosis with polyangiitis (Churg-Strauss)"</a> and  <a class="medical medical_review" href="/z/d/html/4324.html" rel="external">"Pulmonary lymphomatoid granulomatosis"</a> and  <a class="medical medical_review" href="/z/d/html/4322.html" rel="external">"Bronchocentric granulomatosis"</a>.)</p><p class="headingAnchor" id="H5487051"><span class="h3">Bronchocentric granulomatosis</span><span class="headingEndMark"> — </span>In bronchocentric granulomatosis, granulomatous inflammation is centered on the bronchi and is typically associated with mucoid impaction of the bronchus. Frequently, bronchocentric granulomatosis is seen in the context of allergic bronchopulmonary aspergillosis (ABPA). In ABPA, septated fungal hyphae with acute dichotomous branching may be seen in the mucus-filled bronchial lumen, but the fungi do not invade the mucosa. (See  <a class="medical medical_review" href="/z/d/html/4322.html" rel="external">"Bronchocentric granulomatosis"</a> and  <a class="medical medical_review" href="/z/d/html/2419.html" rel="external">"Clinical manifestations and diagnosis of allergic bronchopulmonary aspergillosis"</a>.)</p><p class="headingAnchor" id="H11388835"><span class="h2">Other diffuse parenchymal lung diseases</span><span class="headingEndMark"> — </span>There are numerous additional causes of diffuse parenchymal lung disease that are not classified as interstitial pneumonias, but are considered in the differential diagnosis. These include eosinophilic pneumonia, pulmonary hemorrhage syndromes, alveolar proteinosis, amyloid deposition, smooth muscle proliferation, honeycomb lung, and unclassifiable interstitial pneumonia.</p><p class="headingAnchor" id="H5487133"><span class="h3">Eosinophilic pneumonia</span><span class="headingEndMark"> — </span>The histologic features of eosinophilic pneumonia are similar to those of OP described above, except there is significant eosinophilic infiltration. The eosinophilic infiltration is often accompanied by foci of necrosis and proteinaceous debris, termed eosinophilic microabscesses  (<a class="graphic graphic_picture graphicRef74556" href="/z/d/graphic/74556.html" rel="external">picture 15</a> and <a class="graphic graphic_picture graphicRef58648" href="/z/d/graphic/58648.html" rel="external">picture 16</a> and <a class="graphic graphic_picture graphicRef77554" href="/z/d/graphic/77554.html" rel="external">picture 17</a>). Acute and organizing DAD may also be present, particularly in acute eosinophilic pneumonia.</p><p>In addition to the idiopathic acute and chronic eosinophilic pneumonias, potential causes (or associations) of eosinophilic pneumonia are listed in the table and include parasitic infections, drugs, EGPA, allergic bronchopulmonary aspergillosis, neoplasms, and the hypereosinophilic syndromes  (<a class="graphic graphic_table graphicRef60491" href="/z/d/graphic/60491.html" rel="external">table 10</a>). (See  <a class="medical medical_review" href="/z/d/html/5715.html" rel="external">"Overview of pulmonary eosinophilia", section on 'Idiopathic acute eosinophilic pneumonia'</a> and  <a class="medical medical_review" href="/z/d/html/5715.html" rel="external">"Overview of pulmonary eosinophilia", section on 'Chronic eosinophilic pneumonia'</a>.)</p><p class="headingAnchor" id="H5487126"><span class="h3">Pulmonary hemorrhage syndromes</span><span class="headingEndMark"> — </span>The important histopathologic finding in the pulmonary hemorrhage syndromes is the filling of alveoli with red blood cells and macrophages containing darkly pigmented clumps of hemosiderin (hemosiderin-laden macrophages). When greater than 20 percent of 200 macrophages stain positive for hemosiderin, a diagnosis of diffuse alveolar hemorrhage is usually made. The presence of hemosiderin-laden macrophages helps exclude surgical bleeding as the cause of alveolar red blood cells. Causes of the diffuse alveolar hemorrhage syndromes are listed in the table  (<a class="graphic graphic_table graphicRef52374" href="/z/d/graphic/52374.html" rel="external">table 11</a>). (See  <a class="medical medical_review" href="/z/d/html/4341.html" rel="external">"The diffuse alveolar hemorrhage syndromes"</a>.)</p><p>Often the underlying lesion in pulmonary hemorrhage is a capillaritis with neutrophilic infiltration of the alveolar septa. This leads to necrosis of these structures, loss of capillary structural integrity, and extravasation of erythrocytes into the alveolar space. Many of the tissue neutrophils are fragmented and eventually become pyknotic; the fragmented neutrophils and nuclear dust fibrin may also enter the alveoli with the red blood cells. True fibrinoid necrosis of the interstitium is sometimes seen, and erythrocytes may also be observed within the interstitial space.</p><p>Pulmonary hemorrhage can also occur in the setting of diffuse alveolar damage when the severity of the lung injury leads to marked capillary fragility and leakiness. Diffuse alveolar damage is discussed separately. (See <a class="local">'Diffuse alveolar damage'</a> above and  <a class="medical medical_review" href="/z/d/html/4341.html" rel="external">"The diffuse alveolar hemorrhage syndromes", section on 'Diffuse alveolar damage'</a>.)</p><p>Pulmonary hemorrhage without inflammation of the alveolar structures may be seen in coagulation disorders and in idiopathic pulmonary hemosiderosis. (See  <a class="medical medical_review" href="/z/d/html/4318.html" rel="external">"Idiopathic pulmonary hemosiderosis", section on 'Histopathology'</a>.)</p><p class="headingAnchor" id="H5487084"><span class="h3">Pulmonary alveolar proteinosis</span><span class="headingEndMark"> — </span>In pulmonary alveolar proteinosis (PAS), the alveoli are filled with acellular pink and finely granular lipoproteinaceous material that stains positively with a PAS stain for glycogen. Scattered clefts of cholesterol crystals may be seen within the alveolar exudate [<a href="#rid36">36</a>]. The alveolar septa may be slightly thickened, but the normal alveolar architecture tends to be preserved. Typically, there is little or no inflammatory cell infiltration.</p><p>Potential causes (or associations) of alveolar proteinosis are listed in the table  (<a class="graphic graphic_table graphicRef59965" href="/z/d/graphic/59965.html" rel="external">table 12</a>). (See  <a class="medical medical_review" href="/z/d/html/6351.html" rel="external">"Pulmonary alveolar proteinosis in children", section on 'Diagnosis'</a> and  <a class="medical medical_review" href="/z/d/html/4373.html" rel="external">"Causes, clinical manifestations, and diagnosis of pulmonary alveolar proteinosis in adults"</a> and  <a class="medical medical_review" href="/z/d/html/4373.html" rel="external">"Causes, clinical manifestations, and diagnosis of pulmonary alveolar proteinosis in adults", section on 'Diagnostic evaluation'</a>.)</p><p class="headingAnchor" id="H5487091"><span class="h3">Pulmonary amyloidosis</span><span class="headingEndMark"> — </span>Deposition of amyloid in the lung can cause diffuse alveolar septal thickening, single or multiple pulmonary nodules, or diffuse tracheobronchial lesions. The amyloid deposits appear as amorphous hyaline material on light microscopy. The amyloid fibrils bind Congo red (leading to green birefringence under polarized light) and thioflavine T (producing an intense yellow-green fluorescence). (See  <a class="medical medical_review" href="/z/d/html/5589.html" rel="external">"Overview of amyloidosis", section on 'Selection of biopsy site'</a>.)</p><p>Amyloid deposition can be localized to the lung or be systemic, with the latter having a worse prognosis. It may be seen in association with multiple myeloma, LIP, or primary pulmonary marginal zone lymphomas of mucosa associated lymphoid tissue (MALT) origin. AL-type of amyloid is typical in symptomatic patients. (See  <a class="medical medical_review" href="/z/d/html/5589.html" rel="external">"Overview of amyloidosis", section on 'Pulmonary disease'</a> and  <a class="medical medical_review" href="/z/d/html/4733.html" rel="external">"Clinical manifestations, pathologic features, and diagnosis of extranodal marginal zone lymphoma of mucosa associated lymphoid tissue (MALT)"</a>.)</p><p class="headingAnchor" id="H5487105"><span class="h3">Smooth muscle proliferation</span><span class="headingEndMark"> — </span>Metaplastic smooth muscle proliferation within the lung interstitium can been seen in several conditions, including lymphangioleiomyomatosis (LAM), benign metastasizing leiomyoma, and diffuse primary or metastatic spindle cell malignancy. Most cases of LAM are diagnosed without lung biopsy due to the diagnostic accuracy of HRCT. The evaluation and diagnosis of LAM are discussed separately. (See  <a class="medical medical_review" href="/z/d/html/4335.html" rel="external">"Sporadic lymphangioleiomyomatosis: Epidemiology and pathogenesis"</a>.)</p><p class="headingAnchor" id="H8282262"><span class="h3">Honeycomb lung</span><span class="headingEndMark"> — </span>Honeycomb lung is indicative of end-stage pulmonary fibrosis. Many disorders (eg, IPF, sarcoidosis, hypersensitivity pneumonia, eosinophilic granuloma) can progress to end-stage fibrosis, but cannot be distinguished reliably by pathologists at this stage of the disease processes. Thus, biopsy of extensive honeycomb lung is not helpful and should be avoided.</p><p class="headingAnchor" id="H23696078"><span class="h2">Rare histopathologic interstitial pneumonia patterns</span><span class="headingEndMark"> — </span>Rare histologic interstitial pneumonia patterns have been described: idiopathic pleuroparenchymal fibroelastosis, acute fibrinous and organizing pneumonia, and bronchiolocentric fibroinflammation. It is not clear that these are separate entities or are variants of existing idiopathic interstitial pneumonias, connective tissue diseases, or drug reactions.</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Idiopathic pleuroparenchymal fibroelastosis (PPFE)</strong> is a rare process that consists of upper lobe pleural and subpleural lung parenchymal fibrosis [<a href="#rid37">37</a>]. Special stains are required to reveal the an abnormal accumulation of elastin in the lung tissue. The histologic presentation may include other patterns, such as UIP or NSIP in other parts of the lung [<a href="#rid38">38-40</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Acute fibrinous and organizing pneumonia (AFOP)</strong> is a histologic pattern characterized by intraalveolar fibrin deposition and associated OP, but without the hyaline membranes found in DAD [<a href="#rid41">41-44</a>]. The distribution of AFOP is patchy, typically involving the alveoli and terminal bronchioles, whereas DAD is diffuse and affects all aspects of the lung parenchyma. It is unclear whether AFOP is a distinct entity or a part of the spectrum of DAD and OP. It is associated with a clinical picture of acute lung injury and can be idiopathic or associated with other processes such as hypersensitivity pneumonitis, infection, drug toxicity, eosinophilic pneumonia, and rheumatic disease [<a href="#rid41">41,42,45-47</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Bronchiolocentric fibroinflammatory changes </strong>consisting of peribronchiolar metaplasia are a common focal finding in a variety of idiopathic interstitial pneumonias. Rarely, however, peribronchiolar metaplasia is the only major histologic finding in surgical lung biopsies from patients with interstitial lung disease [<a href="#rid48">48,49</a>]. The term, airway-centered interstitial fibrosis, has been applied to this presentation in some cases. Affected patients are commonly women in middle to older age. (See  <a class="medical medical_review" href="/z/d/html/4323.html" rel="external">"Overview of bronchiolar disorders in adults", section on 'Airway-centered interstitial fibrosis'</a>.)</p><p></p><p class="headingAnchor" id="H5487112"><span class="h2">Unclassifiable interstitial pneumonia</span><span class="headingEndMark"> — </span>Unclassifiable interstitial pneumonia exists when histologic features do not allow classification into one of the above categories  (<a class="graphic graphic_table graphicRef54054" href="/z/d/graphic/54054.html" rel="external">table 13</a>) [<a href="#rid17">17,21,50,51</a>]. Some of these cases result from sampling error or inadequate specimens. This finding on a transbronchial lung biopsy should prompt a surgical lung biopsy.</p><p class="headingAnchor" id="H1594741068"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/z/d/html/118793.html" rel="external">"Society guideline links: Interstitial lung disease"</a>.)</p><p class="headingAnchor" id="H5486114"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Use of histopathology in the diagnosis of ILD</strong> – Collaboration between the clinician, radiologist, and pathologist is needed to identify the most accurate diagnosis when analyzing lung biopsy findings in diffuse parenchymal lung disease. Histopathologic patterns are often "consistent with" a specific diagnosis rather than being diagnostic, so information regarding age, sex, drug use, smoking, occupational and environmental exposures, co-morbid disease, and radiographic findings contributes to the diagnostic process. (See <a class="local">'Multidisciplinary discussion'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Histopathologic patterns</strong> – Histopathologic patterns of diffuse parenchymal lung disease can be broadly divided into interstitial pneumonias, granulomatous lung diseases, and other disorders  (<a class="graphic graphic_algorithm graphicRef77345" href="/z/d/graphic/77345.html" rel="external">algorithm 1</a>). (See <a class="local">'Interpretation of histopathologic patterns'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Idiopathic interstitial pneumonias</strong> – The idiopathic interstitial pneumonias are classified according to seven histologic patterns: usual interstitial pneumonia (UIP), nonspecific interstitial pneumonia (NSIP), desquamative interstitial pneumonia (DIP), respiratory bronchiolitis (RB), organizing pneumonia (OP), lymphoid interstitial pneumonia (LIP), and diffuse alveolar damage (DAD). (See <a class="local">'Interstitial pneumonias'</a> above.) </p><p></p><p class="bulletIndent1">The histologic patterns that typify the idiopathic interstitial pneumonias can also be seen in other disease processes that need to be considered in the differential. Disease processes associated with the histopathologic patterns of UIP  (<a class="graphic graphic_table graphicRef61334" href="/z/d/graphic/61334.html" rel="external">table 1</a>), NSIP  (<a class="graphic graphic_table graphicRef60068" href="/z/d/graphic/60068.html" rel="external">table 2</a>), DIP  (<a class="graphic graphic_table graphicRef58956" href="/z/d/graphic/58956.html" rel="external">table 3</a>), RB-ILD  (<a class="graphic graphic_table graphicRef60250" href="/z/d/graphic/60250.html" rel="external">table 4</a>), OP  (<a class="graphic graphic_table graphicRef87710" href="/z/d/graphic/87710.html" rel="external">table 5</a>), LIP  (<a class="graphic graphic_table graphicRef70714" href="/z/d/graphic/70714.html" rel="external">table 7</a>), and DAD  (<a class="graphic graphic_table graphicRef54819" href="/z/d/graphic/54819.html" rel="external">table 8</a>) are listed in the tables. (See <a class="local">'Interstitial pneumonias'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Granulomatous lung diseases</strong> – When evaluating granulomatous lung disease, the first step is to exclude infection (eg, mycobacteria, fungi). The common noninfectious granulomatous lung diseases include sarcoidosis, hypersensitivity pneumonitis, pulmonary Langerhans cell histiocytosis, and chronic beryllium disease. Other granulomatous lung diseases are listed in the table  (<a class="graphic graphic_table graphicRef56028" href="/z/d/graphic/56028.html" rel="external">table 9</a>). (See <a class="local">'Granulomatous lung diseases'</a> above.)</p><p></p><p class="bulletIndent1">The granulomas seen in granulomatosis with polyangiitis are typically angiocentric and associated with evidence of vascular inflammation. (See <a class="local">'Granulomatous lung diseases'</a> above and  <a class="medical medical_review" href="/z/d/html/4330.html" rel="external">"Granulomatosis with polyangiitis and microscopic polyangiitis: Respiratory tract involvement", section on 'Histopathology'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Other diffuse parenchymal lung diseases</strong> – Causes of diffuse parenchymal lung disease that are not classified as interstitial pneumonias, but are considered in the differential diagnosis, include eosinophilic pneumonia, the pulmonary hemorrhage syndromes, alveolar proteinosis, amyloid deposition, smooth muscle proliferation, and honeycomb lung. (See <a class="local">'Other diffuse parenchymal lung diseases'</a> above.)</p><p></p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Flaherty KR, King TE Jr, Raghu G, et al. Idiopathic interstitial pneumonia: what is the effect of a multidisciplinary approach to diagnosis? Am J Respir Crit Care Med 2004; 170:904.</a></li><li><a class="nounderline abstract_t">Hunninghake GW, Zimmerman MB, Schwartz DA, et al. Utility of a lung biopsy for the diagnosis of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2001; 164:193.</a></li><li class="breakAll">Leslie KO, Colby TV, Lynch DA. Anatomic distribution and histopathologic patterns of interstitial lung disease. In: Interstitial Lung Disease, 5th, Schwartz MI, King TE, Jr (Eds), People's Medical Publishing House, Shelton, CT 2011. p.35.</li><li><a class="nounderline abstract_t">Walsh SL, Wells AU, Desai SR, et al. Multicentre evaluation of multidisciplinary team meeting agreement on diagnosis in diffuse parenchymal lung disease: a case-cohort study. Lancet Respir Med 2016; 4:557.</a></li><li><a class="nounderline abstract_t">Ageely G, Souza C, De Boer K, et al. The Impact of Multidisciplinary Discussion (MDD) in the Diagnosis and Management of Fibrotic Interstitial Lung Diseases. Can Respir J 2020; 2020:9026171.</a></li><li><a class="nounderline abstract_t">Teoh AKY, Holland AE, Morisset J, et al. Essential Features of an Interstitial Lung Disease Multidisciplinary Meeting: An International Delphi Survey. Ann Am Thorac Soc 2022; 19:66.</a></li><li class="breakAll">Colby TV, Churg AC. Patterns of pulmonary fibrosis. In: 1986 Pathology Annual, Sommers SC, Rosen PP, Fechner RE (Eds), Appleton-Century-Crofts, Norwalk, CT 1986. p.277.</li><li><a class="nounderline abstract_t">Nicholson AG, Addis BJ, Bharucha H, et al. Inter-observer variation between pathologists in diffuse parenchymal lung disease. Thorax 2004; 59:500.</a></li><li><a class="nounderline abstract_t">Flaherty KR, Travis WD, Colby TV, et al. Histopathologic variability in usual and nonspecific interstitial pneumonias. Am J Respir Crit Care Med 2001; 164:1722.</a></li><li><a class="nounderline abstract_t">Nicholson AG, Colby TV, du Bois RM, et al. The prognostic significance of the histologic pattern of interstitial pneumonia in patients presenting with the clinical entity of cryptogenic fibrosing alveolitis. Am J Respir Crit Care Med 2000; 162:2213.</a></li><li><a class="nounderline abstract_t">Wagner JD, Stahler C, Knox S, et al. Clinical utility of open lung biopsy for undiagnosed pulmonary infiltrates. Am J Surg 1992; 164:104.</a></li><li><a class="nounderline abstract_t">Hariri LP, Roden AC, Chung JH, et al. The Role of Surgical Lung Biopsy in the Diagnosis of Fibrotic Interstitial Lung Disease: Perspective from the Pulmonary Fibrosis Foundation. Ann Am Thorac Soc 2021; 18:1601.</a></li><li><a class="nounderline abstract_t">Maldonado F, Danoff SK, Wells AU, et al. Transbronchial Cryobiopsy for the Diagnosis of Interstitial Lung Diseases: CHEST Guideline and Expert Panel Report. Chest 2020; 157:1030.</a></li><li><a class="nounderline abstract_t">Zaizen Y, Kohashi Y, Kuroda K, et al. Concordance between sequential transbronchial lung cryobiopsy and surgical lung biopsy in patients with diffuse interstitial lung disease. Diagn Pathol 2019; 14:131.</a></li><li><a class="nounderline abstract_t">Romagnoli M, Colby TV, Berthet JP, et al. Poor Concordance between Sequential Transbronchial Lung Cryobiopsy and Surgical Lung Biopsy in the Diagnosis of Diffuse Interstitial Lung Diseases. Am J Respir Crit Care Med 2019; 199:1249.</a></li><li><a class="nounderline abstract_t">Troy LK, Grainge C, Corte TJ, et al. Diagnostic accuracy of transbronchial lung cryobiopsy for interstitial lung disease diagnosis (COLDICE): a prospective, comparative study. Lancet Respir Med 2020; 8:171.</a></li><li><a class="nounderline abstract_t">Jones KD. Unclassifiable interstitial lung disease: a pathologist's perspective. Eur Respir Rev 2018; 27.</a></li><li><a class="nounderline abstract_t">Travis WD, Costabel U, Hansell DM, et al. An official American Thoracic Society/European Respiratory Society statement: Update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med 2013; 188:733.</a></li><li><a class="nounderline abstract_t">Wells AU, Hansell DM, Nicholson AG. What is this thing called CFA? Thorax 2007; 62:3.</a></li><li><a class="nounderline abstract_t">Churg A, Muller NL, Flint J, Wright JL. Chronic hypersensitivity pneumonitis. Am J Surg Pathol 2006; 30:201.</a></li><li><a class="nounderline abstract_t">Katzenstein AL, Fiorelli RF. Nonspecific interstitial pneumonia/fibrosis. Histologic features and clinical significance. Am J Surg Pathol 1994; 18:136.</a></li><li><a class="nounderline abstract_t">Craig PJ, Wells AU, Doffman S, et al. Desquamative interstitial pneumonia, respiratory bronchiolitis and their relationship to smoking. Histopathology 2004; 45:275.</a></li><li><a class="nounderline abstract_t">Yousem SA, Colby TV, Gaensler EA. Respiratory bronchiolitis-associated interstitial lung disease and its relationship to desquamative interstitial pneumonia. Mayo Clin Proc 1989; 64:1373.</a></li><li><a class="nounderline abstract_t">Niewoehner DE, Kleinerman J, Rice DB. Pathologic changes in the peripheral airways of young cigarette smokers. N Engl J Med 1974; 291:755.</a></li><li><a class="nounderline abstract_t">Myers JL, Veal CF Jr, Shin MS, Katzenstein AL. Respiratory bronchiolitis causing interstitial lung disease. A clinicopathologic study of six cases. Am Rev Respir Dis 1987; 135:880.</a></li><li class="breakAll">Colby TV, Lombard C, Yousem SA, et al. Atlas of Pulmonary Surgical Pathology, WB Saunders, Philadelphia 1991. p.380.</li><li><a class="nounderline abstract_t">Nicholson AG. Lymphocytic interstitial pneumonia and other lymphoproliferative disorders in the lung. Semin Respir Crit Care Med 2001; 22:409.</a></li><li><a class="nounderline abstract_t">Katzenstein AL, Myers JL, Mazur MT. Acute interstitial pneumonia. A clinicopathologic, ultrastructural, and cell kinetic study. Am J Surg Pathol 1986; 10:256.</a></li><li><a class="nounderline abstract_t">Olson J, Colby TV, Elliott CG. Hamman-Rich syndrome revisited. Mayo Clin Proc 1990; 65:1538.</a></li><li class="breakAll">Fulmer JD, Katzenstein AL. The interstitial lung diseases. In: Pulmonary and Critical Care Medicine, Bone RC (Ed), Mosby Year Book, St. Louis 1993. p.M1.</li><li><a class="nounderline abstract_t">Fasano MB, Sullivan KE, Sarpong SB, et al. Sarcoidosis and common variable immunodeficiency. Report of 8 cases and review of the literature. Medicine (Baltimore) 1996; 75:251.</a></li><li><a class="nounderline abstract_t">Popa V, Colby TV, Reich SB. Pulmonary interstitial disease in Ig deficiency. Chest 2002; 122:1594.</a></li><li><a class="nounderline abstract_t">Churg A, Bilawich A, Wright JL. Pathology of Chronic Hypersensitivity Pneumonitis What Is It? What Are the Diagnostic Criteria? Why Do We Care? Arch Pathol Lab Med 2018; 142:109.</a></li><li><a class="nounderline abstract_t">Churg A, Wright JL, Ryerson CJ. Pathologic Separation of Chronic Hypersensitivity Pneumonitis From Fibrotic Connective Tissue Disease-associated Interstitial Lung Disease. Am J Surg Pathol 2017; 41:1403.</a></li><li><a class="nounderline abstract_t">Wright JL, Churg A, Hague CJ, et al. Pathologic separation of idiopathic pulmonary fibrosis from fibrotic hypersensitivity pneumonitis. Mod Pathol 2020; 33:616.</a></li><li><a class="nounderline abstract_t">Villanueva AG, Mark EJ. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 24-1996. A 54-year-old woman with infiltrative lung disease and mild dyspnea. N Engl J Med 1996; 335:417.</a></li><li><a class="nounderline abstract_t">Kusagaya H, Fujisawa T, Enomoto N, et al. Co-occurrence of Pneumoperitoneum and Pneumothorax in a Patient with Pleuroparenchymal Fibroelastosis. Am J Respir Crit Care Med 2015; 191:1200.</a></li><li><a class="nounderline abstract_t">Watanabe K, Nagata N, Kitasato Y, et al. Rapid decrease in forced vital capacity in patients with idiopathic pulmonary upper lobe fibrosis. Respir Investig 2012; 50:88.</a></li><li><a class="nounderline abstract_t">Reddy TL, Tominaga M, Hansell DM, et al. Pleuroparenchymal fibroelastosis: a spectrum of histopathological and imaging phenotypes. Eur Respir J 2012; 40:377.</a></li><li><a class="nounderline abstract_t">Beynat-Mouterde C, Beltramo G, Lezmi G, et al. Pleuroparenchymal fibroelastosis as a late complication of chemotherapy agents. Eur Respir J 2014; 44:523.</a></li><li><a class="nounderline abstract_t">Beasley MB, Franks TJ, Galvin JR, et al. Acute fibrinous and organizing pneumonia: a histological pattern of lung injury and possible variant of diffuse alveolar damage. Arch Pathol Lab Med 2002; 126:1064.</a></li><li><a class="nounderline abstract_t">Hariri LP, Unizony S, Stone J, et al. Acute fibrinous and organizing pneumonia in systemic lupus erythematosus: a case report and review of the literature. Pathol Int 2010; 60:755.</a></li><li><a class="nounderline abstract_t">Damas C, Morais A, Moura CS, Marques A. Acute fibrinous and organizing pneumonia. Rev Port Pneumol 2006; 12:615.</a></li><li><a class="nounderline abstract_t">Bhatti S, Hakeem A, Torrealba J, et al. Severe acute fibrinous and organizing pneumonia (AFOP) causing ventilatory failure: successful treatment with mycophenolate mofetil and corticosteroids. Respir Med 2009; 103:1764.</a></li><li><a class="nounderline abstract_t">Balduin R, Giacometti C, Saccarola L, et al. Acute fibrinous and organizing pneumonia in a patient with collagen vascular disease "stigma". Sarcoidosis Vasc Diffuse Lung Dis 2007; 24:78.</a></li><li><a class="nounderline abstract_t">Yokogawa N, Alcid DV. Acute fibrinous and organizing pneumonia as a rare presentation of abacavir hypersensitivity reaction. AIDS 2007; 21:2116.</a></li><li><a class="nounderline abstract_t">Piciucchi S, Dubini A, Tomassetti S, et al. A case of amiodarone-induced acute fibrinous and organizing pneumonia mimicking mesothelioma. Am J Respir Crit Care Med 2015; 191:104.</a></li><li><a class="nounderline abstract_t">Churg A, Myers J, Suarez T, et al. Airway-centered interstitial fibrosis: a distinct form of aggressive diffuse lung disease. Am J Surg Pathol 2004; 28:62.</a></li><li><a class="nounderline abstract_t">Fukuoka J, Franks TJ, Colby TV, et al. Peribronchiolar metaplasia: a common histologic lesion in diffuse lung disease and a rare cause of interstitial lung disease: clinicopathologic features of 15 cases. Am J Surg Pathol 2005; 29:948.</a></li><li><a class="nounderline abstract_t">Cottin V, Donsbeck AV, Revel D, et al. Nonspecific interstitial pneumonia. Individualization of a clinicopathologic entity in a series of 12 patients. Am J Respir Crit Care Med 1998; 158:1286.</a></li><li><a class="nounderline abstract_t">Daniil ZD, Gilchrist FC, Nicholson AG, et al. A histologic pattern of nonspecific interstitial pneumonia is associated with a better prognosis than usual interstitial pneumonia in patients with cryptogenic fibrosing alveolitis. Am J Respir Crit Care Med 1999; 160:899.</a></li></ol></div><div id="topicVersionRevision">Topic 16921 Version 29.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15256390" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Idiopathic interstitial pneumonia: what is the effect of a multidisciplinary approach to diagnosis?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11463586" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Utility of a lung biopsy for the diagnosis of idiopathic pulmonary fibrosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11463586" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Utility of a lung biopsy for the diagnosis of idiopathic pulmonary fibrosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27180021" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Multicentre evaluation of multidisciplinary team meeting agreement on diagnosis in diffuse parenchymal lung disease: a case-cohort study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32879642" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : The Impact of Multidisciplinary Discussion (MDD) in the Diagnosis and Management of Fibrotic Interstitial Lung Diseases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34191689" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Essential Features of an Interstitial Lung Disease Multidisciplinary Meeting: An International Delphi Survey.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34191689" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Essential Features of an Interstitial Lung Disease Multidisciplinary Meeting: An International Delphi Survey.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15170033" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Inter-observer variation between pathologists in diffuse parenchymal lung disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11719316" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Histopathologic variability in usual and nonspecific interstitial pneumonias.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11112140" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : The prognostic significance of the histologic pattern of interstitial pneumonia in patients presenting with the clinical entity of cryptogenic fibrosing alveolitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1636888" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Clinical utility of open lung biopsy for undiagnosed pulmonary infiltrates.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34004127" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : The Role of Surgical Lung Biopsy in the Diagnosis of Fibrotic Interstitial Lung Disease: Perspective from the Pulmonary Fibrosis Foundation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31783014" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Transbronchial Cryobiopsy for the Diagnosis of Interstitial Lung Diseases: CHEST Guideline and Expert Panel Report.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31801596" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Concordance between sequential transbronchial lung cryobiopsy and surgical lung biopsy in patients with diffuse interstitial lung disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30864813" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Poor Concordance between Sequential Transbronchial Lung Cryobiopsy and Surgical Lung Biopsy in the Diagnosis of Diffuse Interstitial Lung Diseases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31578168" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Diagnostic accuracy of transbronchial lung cryobiopsy for interstitial lung disease diagnosis (COLDICE): a prospective, comparative study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29491037" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Unclassifiable interstitial lung disease: a pathologist's perspective.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24032382" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : An official American Thoracic Society/European Respiratory Society statement: Update of the international multidisciplinary classification of the idiopathic interstitial pneumonias.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17189529" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : What is this thing called CFA?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16434894" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Chronic hypersensitivity pneumonitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8291652" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Nonspecific interstitial pneumonia/fibrosis. Histologic features and clinical significance.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15330806" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Desquamative interstitial pneumonia, respiratory bronchiolitis and their relationship to smoking.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2593722" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Respiratory bronchiolitis-associated interstitial lung disease and its relationship to desquamative interstitial pneumonia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4414996" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Pathologic changes in the peripheral airways of young cigarette smokers.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3565934" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Respiratory bronchiolitis causing interstitial lung disease. A clinicopathologic study of six cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3565934" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Respiratory bronchiolitis causing interstitial lung disease. A clinicopathologic study of six cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16088689" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Lymphocytic interstitial pneumonia and other lymphoproliferative disorders in the lung.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3706612" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Acute interstitial pneumonia. A clinicopathologic, ultrastructural, and cell kinetic study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2255216" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Hamman-Rich syndrome revisited.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2255216" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Hamman-Rich syndrome revisited.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8862347" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Sarcoidosis and common variable immunodeficiency. Report of 8 cases and review of the literature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12426258" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Pulmonary interstitial disease in Ig deficiency.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28537805" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Pathology of Chronic Hypersensitivity Pneumonitis What Is It? What Are the Diagnostic Criteria? Why Do We Care?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28614213" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Pathologic Separation of Chronic Hypersensitivity Pneumonitis From Fibrotic Connective Tissue Disease-associated Interstitial Lung Disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31659276" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Pathologic separation of idiopathic pulmonary fibrosis from fibrotic hypersensitivity pneumonitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8676935" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 24-1996. A 54-year-old woman with infiltrative lung disease and mild dyspnea.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25978573" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Co-occurrence of Pneumoperitoneum and Pneumothorax in a Patient with Pleuroparenchymal Fibroelastosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23021767" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Rapid decrease in forced vital capacity in patients with idiopathic pulmonary upper lobe fibrosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22441748" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Pleuroparenchymal fibroelastosis: a spectrum of histopathological and imaging phenotypes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24791830" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Pleuroparenchymal fibroelastosis as a late complication of chemotherapy agents.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12204055" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Acute fibrinous and organizing pneumonia: a histological pattern of lung injury and possible variant of diffuse alveolar damage.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20946526" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Acute fibrinous and organizing pneumonia in systemic lupus erythematosus: a case report and review of the literature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17117329" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Acute fibrinous and organizing pneumonia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19666216" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Severe acute fibrinous and organizing pneumonia (AFOP) causing ventilatory failure: successful treatment with mycophenolate mofetil and corticosteroids.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18069424" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Acute fibrinous and organizing pneumonia in a patient with collagen vascular disease "stigma".</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17885309" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Acute fibrinous and organizing pneumonia as a rare presentation of abacavir hypersensitivity reaction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25551348" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : A case of amiodarone-induced acute fibrinous and organizing pneumonia mimicking mesothelioma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14707865" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Airway-centered interstitial fibrosis: a distinct form of aggressive diffuse lung disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15958861" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Peribronchiolar metaplasia: a common histologic lesion in diffuse lung disease and a rare cause of interstitial lung disease: clinicopathologic features of 15 cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9769293" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Nonspecific interstitial pneumonia. Individualization of a clinicopathologic entity in a series of 12 patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10471616" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : A histologic pattern of nonspecific interstitial pneumonia is associated with a better prognosis than usual interstitial pneumonia in patients with cryptogenic fibrosing alveolitis.</p>
</a>
</div>
</div>
</div>
</div>
</section>
</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->
<!-- End Footer Area -->
<!-- Back to top -->
<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->
<!-- Prpper JS -->
<!-- Bootstrap Min JS -->
<!-- Classy Nav Min Js -->
<!-- Owl Carousel Min Js -->
<!-- Magnific Popup JS -->
<!-- CounterUp JS -->
<!-- Waypoints JS -->
<!-- Form Validator Min JS -->
<!-- Contact Form Min JS -->
<!-- Main JS -->
<!-- Global site tag (gtag.js) - Google Analytics -->
</body>
</html>
